Systemic therapy options in metastatic CRC are continuously evolving and new treatments are becoming available with utilization of various biomarkers. There is a need to review the current landscape of treatment regimens and have an understanding of their place in therapy. 

LEARNING OBJECTIVES

Following this activity, participants should be able to:

• Choose appropriate chemotherapy regimens for metastatic colorectal cancer (mCRC) based on patient and tumor characteristics
• Interpret the role of biomarkers for choosing treatment regimens in mCRC
• Identify the toxicities associated with newly available treatment regimens for mCRC

Event starts: 06/04/2021 - 2:30pm

Event ends:  06/04/2021 - 3:30pm

Cost: FREE

More info: https://education.nccn.org/node/89225